<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>110(1)</volume><submitter>Lasagna A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Patients with cancer present a higher risk of vaccine-preventable diseases. Recommended vaccinations are the most cost-effective measure to reduce the risk of transmission and related complications. Nevertheless, vaccination rates are inadequate. Oncologists have a central role in tailored vaccine communication to their patients. We present the results of a survey conducted by AIOM in 2022, focusing on the perception of the problem by oncologists.&lt;h4>Materials and methods&lt;/h4>An anonymous 31-item online questionnaire was shared on 15 September 2022 on the AIOM website. The objectives of this survey were to examine the perception of Italian oncologists on vaccine-preventable diseases and the main available vaccines, their attitude towards recommending vaccines and the COV</pubmed_abstract><journal>Tumori</journal><pagination>60-68</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10851644</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology.</pubmed_title><pmcid>PMC10851644</pmcid><pubmed_authors>Brunello A</pubmed_authors><pubmed_authors>Lasagna A</pubmed_authors><pubmed_authors>Cinieri S</pubmed_authors><pubmed_authors>Silvestris N</pubmed_authors><pubmed_authors>Pedrazzoli P</pubmed_authors><pubmed_authors>Di Maio M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology.</name><description>&lt;h4>Background&lt;/h4>Patients with cancer present a higher risk of vaccine-preventable diseases. Recommended vaccinations are the most cost-effective measure to reduce the risk of transmission and related complications. Nevertheless, vaccination rates are inadequate. Oncologists have a central role in tailored vaccine communication to their patients. We present the results of a survey conducted by AIOM in 2022, focusing on the perception of the problem by oncologists.&lt;h4>Materials and methods&lt;/h4>An anonymous 31-item online questionnaire was shared on 15 September 2022 on the AIOM website. The objectives of this survey were to examine the perception of Italian oncologists on vaccine-preventable diseases and the main available vaccines, their attitude towards recommending vaccines and the COV</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-03-27T16:29:14.17Z</modification><creation>2025-04-05T16:22:47.424Z</creation></dates><accession>S-EPMC10851644</accession><cross_references><pubmed>37586016</pubmed><doi>10.1177/03008916231191547</doi></cross_references></HashMap>